ScholarGate
Get started

Method evidence record

MelasQoL

MelasQoL is a disease-specific, patient-administered quality-of-life measure designed to assess the psychosocial burden of melasma, a common chronic disorder of symmetric facial hyperpigmentation. Developed by Cestari and colleagues in 2006, it captures the unique emotional and social impacts of a predominantly cosmetic condition that disproportionately affects women of color. MelasQoL is essential in clinical trials and observational studies of melasma treatments to ensure that efficacy encompasses meaningful quality-of-life outcomes.

Evidence statusSources recorded, not reviewedBibliographic sources are present. Claim-level evidence review has not been performed.

Source record

Recorded

Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.

Melasma Quality of Life Scale

Taxonomic method recordprocess-pipelinedermatology

  1. Cestari TF, Hexsel D, Brandt FS, et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL. Br J Dermatol. 2006;156(Suppl 3):13-20. · URL

  2. Pandya AG, Hynan LS, Bhore R, et al. Reliability and validity of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64(1):78-83. · URL

Open full method2 recorded citations, copied from the method source record.

Curated claims

Assessed

Claims persisted in the evidence ledger, each with its own assessment.

No curated claims yet

This view does not invent a claim assessment when the ledger has none.

Related methods

Suggested3

Generated from the method graph and shown as machine-suggested relations. No evidence claim is inferred.